Translating pharmacogenomics discoveries into the clinic: An implementation framework

Genome Medicine

Volumn 5, Issue 10, 2013, Pages

  Huang, R S ^a   Gamazon, Eric R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CLOPIDOGREL; CODEINE; MERCAPTOPURINE; PROTON PUMP INHIBITOR; SIMVASTATIN; WARFARIN;

ADOPTION; ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC TEST; DRUG RESPONSE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEALTH; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEREDITY; HOSPITAL; HUMAN; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK; SCORING SYSTEM; UNSPECIFIED SIDE EFFECT; CONCEPT ANALYSIS; CONCEPTUAL FRAMEWORK; MEDICAL RESEARCH; PATIENT CARE; PHARMACEUTICAL CARE; STANDARDIZATION;

EID: 84886234199     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm497     Document Type: Article

References (7)

1. Huang RS, Ratain MJ. Pharmacogenetics and pharmacogenomics of anticancer agents. CA Cancer J Clin 2009, 59:42-55. 10.3322/caac.20002, 3109906, 19147868.
2. Gharani N, Keller MA, CB S, Hodges LM, Schmidlen TJ, et al. The coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system. Genome Med 2013, 5:93.
3. Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther 2011, 89:464-467. 10.1038/clpt.2010.279, 3098762,3098762, 21270786.
4. Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, Rongen GA, van Schaik RH, Schalekamp T, Touw DJ, van der Weide J, Wilffert B, Deneer VH, Guchelaar HJ. Pharmacogenetics: from bench to byte - an update of guidelines. Clin Pharmacol Ther 2011, 89:662-673. 10.1038/clpt.2011.34, 21412232.
5. Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO. EGAPP Working Group The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet Med 2009, 11:3-14. 10.1097/GIM.0b013e318184137c, 2743609, 18813139, EGAPP Working Group.
6. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
7. Gamazon ER, Perera M. Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges. Pharmacogenomics 2012, 13:1101-1104. 10.2217/pgs.12.88, 3710727, 22909197.